Morphic Therapeutic is leading the development of a new generation of oral integrin drugs, informed by decades of world-leading expertise and a unique integrin discovery platform.

Pharmaceutical

Morphic Therapeutic

Morphic Therapeutic's headquarters in Waltham, MA, United States

Praveen Tipirneni

Brihad Abhyankar

Yujun Wu

Monica Serrano

Joanne Gibbons

Chris Erdman

Marc Schegerin

Scott L. Friedman

Otello Stampacchia

Gustav Christensen

Martin Edwards

Timothy Springer

Yury V. Popov

Norbert Bischofberger

Ulrich H. Von Andrian

Susannah Gray

Silvio Danese

Laurent Peyrin-Biroulet

Bruce Sands

Brian G. Feagan

Stefan Schreiber

Albert Robichaud

Shelia Violette

The Scientific and Clinical Research Team at Morphic Therapeutic is responsible for advancing the development of oral integrin drugs through rigorous scientific exploration and clinical trials. Comprising experts in scientific advising, clinical research, medicinal chemistry, bioinformatics, and data architecture, the team collaborates to ensure the innovative discovery platform translates effectively into impactful therapeutic solutions. They conduct preclinical and clinical studies, optimize drug candidates, and leverage cutting-edge data analysis to enable groundbreaking advancements in integrin-targeted therapies.

Scientific and Clinical Research Team

The team comprising multiple Directors at Morphic Therapeutic focuses on strategic oversight and leadership across various departments such as lab operations, payroll, finance, quality management, people operations, translational sciences, and information technology. They ensure that the company's initiatives align with its mission to develop innovative oral integrin drugs, leveraging their expertise to drive organizational success and groundbreaking discoveries.

Director

The Clinical Operations Team at Morphic Therapeutic oversees the planning, execution, and management of clinical trials to ensure the successful development of oral integrin drugs. This team coordinates logistics, manages clinical supply chains, handles biostatistics, and ensures regulatory compliance, facilitating the passage from concept to clinical application.

Clinical Operations Team

The Corporate Management & Operations Team at Morphic Therapeutic oversees strategic business development, financial management, legal compliance, investor relations, and regulatory affairs. This team ensures operational efficiency and corporate governance, while also fostering relationships with investors and maintaining rigorous quality standards for the company's pioneering oral integrin drugs.

Corporate Management & Operations Team

The Scientific & Clinical Development Team at Morphic Therapeutic is responsible for the strategic planning and execution of clinical trials and scientific research to advance the development of oral integrin drugs. They ensure the safety, efficacy, and bioanalytical evaluation of the compounds, leveraging their expertise in chemistry, pharmacology, and safety assessment to drive successful drug development.

Scientific & Clinical Development Team

The Leadership Team at Morphic Therapeutic is responsible for steering the company's strategic vision and driving innovation in the development of oral integrin drugs. Comprising key executives, including the President & CEO and Chief Scientific Officer, the team collaborates to ensure operational excellence, financial sustainability, and the advancement of research initiatives, while fostering a culture of scientific integrity and collaboration.

Morphic Therapeutic

Org chart

Board & advisors

Teams

Scientific and Clinical Research Team

Director

Clinical Operations Team

Corporate Management & Operations Team

Scientific & Clinical Development Team

Leadership Team

Offices

Morphic Therapeutic

Org chart

Board & advisors

Teams

Scientific and Clinical Research Team

Director

Clinical Operations Team

Corporate Management & Operations Team

Scientific & Clinical Development Team

Leadership Team

Offices

Related companies